Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Non-Current Debt (2016 - 2017)

Historic Non-Current Debt for Lisata Therapeutics (LSTA) over the last 8 years, with Q2 2017 value amounting to $23290.0.

  • Lisata Therapeutics' Non-Current Debt fell 9938.92% to $23290.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $23290.0, marking a year-over-year decrease of 9938.92%. This contributed to the annual value of $2.5 million for FY2016, which is 7668.3% down from last year.
  • Latest data reveals that Lisata Therapeutics reported Non-Current Debt of $23290.0 as of Q2 2017, which was down 9938.92% from $4.4 million recorded in Q1 2017.
  • Lisata Therapeutics' 5-year Non-Current Debt high stood at $15.0 million for Q3 2014, and its period low was $23290.0 during Q2 2017.
  • In the last 5 years, Lisata Therapeutics' Non-Current Debt had a median value of $4.1 million in 2016 and averaged $6.0 million.
  • As far as peak fluctuations go, Lisata Therapeutics' Non-Current Debt soared by 420664.46% in 2014, and later plummeted by 9938.92% in 2017.
  • Lisata Therapeutics' Non-Current Debt (Quarter) stood at $531164.0 in 2013, then soared by 2515.08% to $13.9 million in 2014, then fell by 22.04% to $10.8 million in 2015, then plummeted by 76.68% to $2.5 million in 2016, then plummeted by 99.08% to $23290.0 in 2017.
  • Its Non-Current Debt was $23290.0 in Q2 2017, compared to $4.4 million in Q1 2017 and $2.5 million in Q4 2016.